Key result
Red wine polyphenols significantly reduced systolic blood pressure by 2.6 mmHg overall in human studies, with a greater reduction of 3.7 mmHg observed in pure-resveratrol studies.
Why the study?
The study aimed to quantify and compare the efficacy of red wine polyphenols and pure resveratrol on vascular health and function outcomes in both animals and humans.
Does oral supplementation with red wine polyphenols or pure resveratrol improve blood pressure and vascular function in animal models and human populations?
Meta-Analysis
Does oral supplementation with red wine polyphenols or pure resveratrol improve blood pressure and vascular function in animal models and human populations?
Mean Difference: -2.6 (95% CI -4.8–-0.4)
p-value: p=0.010
Red wine polyphenols, particularly pure resveratrol, significantly lower systolic blood pressure in humans, though the benefits are less pronounced than in animal models.
May support adjunctive resveratrol for systolic BP control; confirms animal benefits in human RCTs.
PURPOSE: Red wine polyphenols (RWP) are plant-based molecules that have been extensively studied in relation to their protective effects on vascular health in both animals and humans. The aim of this review was to quantify and compare the efficacy of RWP and pure resveratrol on outcomes measures of vascular health and function in both animals and humans. METHODS: Comprehensive database searches were carried out through PubMed, Web of Science and OVID for randomised, placebo-controlled studies in both animals and humans. Meta-analyses were carried out on acute and chronic studies of RWP in humans, alongside sub-group analysis where possible. Risk-of-bias assessment was carried out for all included studies based on randomisation, allocation, blinding, outcome data reporting, and other biases. RESULTS: 48 animal and 37 human studies were included in data extraction following screening. Significant improvements in measures of blood pressure and vascular function following RWP were seen in 84% and 100% of animal studies, respectively. Human studies indicated significant improvements in systolic blood pressure overall (- 2.6 mmHg, 95% CI: [- 4.8, - 0.4]), with a greater improvement in pure-resveratrol studies alone (- 3.7 mmHg, 95% CI: [- 7.3, - 0.0]). No significant effects of RWP were seen in diastolic blood pressure or flow-mediated dilation (FMD) of the brachial artery. CONCLUSION: RWP have the potential to improve vascular health in at risk human populations, particularly in regard to lowering systolic blood pressure; however, such benefits are not as prevalent as those observed in animal models.
No takes yet. Share an insight, caveat, or question.
Weaver et al. (2020) conducted a meta-analysis in Vascular health. Red wine polyphenols vs. Placebo was evaluated on Systolic blood pressure (MD -2.6 mmHg, 95% CI -4.8, -0.4, p=0.010). Red wine polyphenols significantly reduced systolic blood pressure by 2.6 mmHg overall in human studies, with a greater reduction of 3.7 mmHg observed in pure-resveratrol studies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: